Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue
1.4 Market Analysis by Type
1.4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CellSearch
1.4.3 Others
1.5 Market by Application
1.5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application: 2020 VS 2026
1.5.2 Breast Cancer Diagnosis and Treatment
1.5.3 Prostate Cancer Diagnosis and Treatment
1.5.4 Colorectal Cancer Diagnosis and Treatment
1.5.5 Lung Cancer Diagnosis and Treatment
1.5.6 Other Cancers Diagnosis and Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Impact
1.6.1 How the Covid-19 is Affecting the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry
1.6.1.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Perspective (2015-2026)
2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Growth Trends by Regions
2.2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Strategy
2.3.6 Primary Interviews with Key Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Market Size
3.1.1 Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Revenue (2015-2020)
3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players (2015-2020)
3.1.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Ratio
3.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2019
3.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players Head office and Area Served
3.4 Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Solution and Service
3.5 Date of Enter into Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Type (2015-2020)
4.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Type (2021-2026)
5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by Application (2015-2026)
5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in North America (2019-2020)
6.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
6.4 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in Europe (2019-2020)
7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
7.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
8 China
8.1 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in China (2019-2020)
8.3 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
8.4 China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in Japan (2019-2020)
9.3 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
9.4 Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
11 India
11.1 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
11.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in India (2019-2020)
11.3 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
11.4 India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2015-2020)
12.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020)
12.4 Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Janssen
13.1.1 Janssen Company Details
13.1.2 Janssen Business Overview and Its Total Revenue
13.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.1.4 Janssen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020))
13.1.5 Janssen Recent Development
13.2 Qiagen
13.2.1 Qiagen Company Details
13.2.2 Qiagen Business Overview and Its Total Revenue
13.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.2.4 Qiagen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.2.5 Qiagen Recent Development
13.3 Advanced Cell Diagnostics
13.3.1 Advanced Cell Diagnostics Company Details
13.3.2 Advanced Cell Diagnostics Business Overview and Its Total Revenue
13.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.3.5 Advanced Cell Diagnostics Recent Development
13.4 ApoCell
13.4.1 ApoCell Company Details
13.4.2 ApoCell Business Overview and Its Total Revenue
13.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.4.4 ApoCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.4.5 ApoCell Recent Development
13.5 Biofluidica
13.5.1 Biofluidica Company Details
13.5.2 Biofluidica Business Overview and Its Total Revenue
13.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.5.4 Biofluidica Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.5.5 Biofluidica Recent Development
13.6 Clearbridge Biomedics
13.6.1 Clearbridge Biomedics Company Details
13.6.2 Clearbridge Biomedics Business Overview and Its Total Revenue
13.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.6.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.6.5 Clearbridge Biomedics Recent Development
13.7 CytoTrack
13.7.1 CytoTrack Company Details
13.7.2 CytoTrack Business Overview and Its Total Revenue
13.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.7.4 CytoTrack Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.7.5 CytoTrack Recent Development
13.8 Celsee
13.8.1 Celsee Company Details
13.8.2 Celsee Business Overview and Its Total Revenue
13.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.8.4 Celsee Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.8.5 Celsee Recent Development
13.9 Fluxion
13.9.1 Fluxion Company Details
13.9.2 Fluxion Business Overview and Its Total Revenue
13.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.9.4 Fluxion Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.9.5 Fluxion Recent Development
13.10 Gilupi
13.10.1 Gilupi Company Details
13.10.2 Gilupi Business Overview and Its Total Revenue
13.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
13.10.4 Gilupi Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
13.10.5 Gilupi Recent Development
13.11 Cynvenio
10.11.1 Cynvenio Company Details
10.11.2 Cynvenio Business Overview and Its Total Revenue
10.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.11.4 Cynvenio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.11.5 Cynvenio Recent Development
13.12 On-chip
10.12.1 On-chip Company Details
10.12.2 On-chip Business Overview and Its Total Revenue
10.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.12.4 On-chip Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.12.5 On-chip Recent Development
13.13 YZY Bio
10.13.1 YZY Bio Company Details
10.13.2 YZY Bio Business Overview and Its Total Revenue
10.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.13.4 YZY Bio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.13.5 YZY Bio Recent Development
13.14 BioView
10.14.1 BioView Company Details
10.14.2 BioView Business Overview and Its Total Revenue
10.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.14.4 BioView Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.14.5 BioView Recent Development
13.15 Fluidigm
10.15.1 Fluidigm Company Details
10.15.2 Fluidigm Business Overview and Its Total Revenue
10.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.15.4 Fluidigm Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.15.5 Fluidigm Recent Development
13.16 Ikonisys
10.16.1 Ikonisys Company Details
10.16.2 Ikonisys Business Overview and Its Total Revenue
10.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.16.4 Ikonisys Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.16.5 Ikonisys Recent Development
13.17 AdnaGen
10.17.1 AdnaGen Company Details
10.17.2 AdnaGen Business Overview and Its Total Revenue
10.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.17.4 AdnaGen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.17.5 AdnaGen Recent Development
13.18 IVDiagnostics
10.18.1 IVDiagnostics Company Details
10.18.2 IVDiagnostics Business Overview and Its Total Revenue
10.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.18.4 IVDiagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.18.5 IVDiagnostics Recent Development
13.19 Miltenyi Biotec
10.19.1 Miltenyi Biotec Company Details
10.19.2 Miltenyi Biotec Business Overview and Its Total Revenue
10.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.19.4 Miltenyi Biotec Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.19.5 Miltenyi Biotec Recent Development
13.20 ScreenCell
10.20.1 ScreenCell Company Details
10.20.2 ScreenCell Business Overview and Its Total Revenue
10.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.20.4 ScreenCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.20.5 ScreenCell Recent Development
13.21 Silicon Biosystems
10.21.1 Silicon Biosystems Company Details
10.21.2 Silicon Biosystems Business Overview and Its Total Revenue
10.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
10.21.4 Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020)
10.21.5 Silicon Biosystems Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Market Segments
Table 2. Key Players Covered: Ranking by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue
Table 3. Ranking of Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CellSearch
Table 6. Key Players of Others
Table 7. COVID-19 Impact Global Market: (Four Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players to Combat Covid-19 Impact
Table 12. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Regions (2015-2020)
Table 16. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Strategy
Table 22. Main Points Interviewed from Key Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players
Table 23. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2015-2020) (Million US$)
Table 24. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Players (2015-2020)
Table 25. Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as of 2019)
Table 26. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Solution and Service
Table 29. Date of Enter into Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 32. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2015-2020)
Table 33. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type (2021-2026)
Table 34. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2015-2020)
Table 35. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 36. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2026)
Table 37. North America Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 39. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 40. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 41. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 42. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 43. Europe Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 45. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 47. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 49. China Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 50. China Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 51. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 52. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 53. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 54. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 55. Japan Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 57. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 59. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 63. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 65. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 67. India Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 68. India Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 69. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 70. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 71. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 72. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share (2019-2020)
Table 75. Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type (2015-2020)
Table 77. Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application (2015-2020)
Table 79. Janssen Company Details
Table 80. Janssen Business Overview
Table 81. Janssen Product
Table 82. Janssen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 83. Janssen Recent Development
Table 84. Qiagen Company Details
Table 85. Qiagen Business Overview
Table 86. Qiagen Product
Table 87. Qiagen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 88. Qiagen Recent Development
Table 89. Advanced Cell Diagnostics Company Details
Table 90. Advanced Cell Diagnostics Business Overview
Table 91. Advanced Cell Diagnostics Product
Table 92. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 93. Advanced Cell Diagnostics Recent Development
Table 94. ApoCell Company Details
Table 95. ApoCell Business Overview
Table 96. ApoCell Product
Table 97. ApoCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 98. ApoCell Recent Development
Table 99. Biofluidica Company Details
Table 100. Biofluidica Business Overview
Table 101. Biofluidica Product
Table 102. Biofluidica Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 103. Biofluidica Recent Development
Table 104. Clearbridge Biomedics Company Details
Table 105. Clearbridge Biomedics Business Overview
Table 106. Clearbridge Biomedics Product
Table 107. Clearbridge Biomedics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 108. Clearbridge Biomedics Recent Development
Table 109. CytoTrack Company Details
Table 110. CytoTrack Business Overview
Table 111. CytoTrack Product
Table 112. CytoTrack Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 113. CytoTrack Recent Development
Table 114. Celsee Business Overview
Table 115. Celsee Product
Table 116. Celsee Company Details
Table 117. Celsee Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 118. Celsee Recent Development
Table 119. Fluxion Company Details
Table 120. Fluxion Business Overview
Table 121. Fluxion Product
Table 122. Fluxion Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 123. Fluxion Recent Development
Table 124. Gilupi Company Details
Table 125. Gilupi Business Overview
Table 126. Gilupi Product
Table 127. Gilupi Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 128. Gilupi Recent Development
Table 129. Cynvenio Company Details
Table 130. Cynvenio Business Overview
Table 131. Cynvenio Product
Table 132. Cynvenio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 133. Cynvenio Recent Development
Table 134. On-chip Company Details
Table 135. On-chip Business Overview
Table 136. On-chip Product
Table 137. On-chip Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 138. On-chip Recent Development
Table 139. YZY Bio Company Details
Table 140. YZY Bio Business Overview
Table 141. YZY Bio Product
Table 142. YZY Bio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 143. YZY Bio Recent Development
Table 144. BioView Company Details
Table 145. BioView Business Overview
Table 146. BioView Product
Table 147. BioView Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 148. BioView Recent Development
Table 149. Fluidigm Company Details
Table 150. Fluidigm Business Overview
Table 151. Fluidigm Product
Table 152. Fluidigm Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 153. Fluidigm Recent Development
Table 154. Ikonisys Company Details
Table 155. Ikonisys Business Overview
Table 156. Ikonisys Product
Table 157. Ikonisys Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 158. Ikonisys Recent Development
Table 159. AdnaGen Company Details
Table 160. AdnaGen Business Overview
Table 161. AdnaGen Product
Table 162. AdnaGen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 163. AdnaGen Recent Development
Table 164. IVDiagnostics Company Details
Table 165. IVDiagnostics Business Overview
Table 166. IVDiagnostics Product
Table 167. IVDiagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 168. IVDiagnostics Recent Development
Table 169. Miltenyi Biotec Company Details
Table 170. Miltenyi Biotec Business Overview
Table 171. Miltenyi Biotec Product
Table 172. Miltenyi Biotec Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 173. Miltenyi Biotec Recent Development
Table 174. ScreenCell Company Details
Table 175. ScreenCell Business Overview
Table 176. ScreenCell Product
Table 177. ScreenCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 178. ScreenCell Recent Development
Table 179. Silicon Biosystems Company Details
Table 180. Silicon Biosystems Business Overview
Table 181. Silicon Biosystems Product
Table 182. Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2015-2020) (Million US$)
Table 183. Silicon Biosystems Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type: 2020 VS 2026
Figure 2. CellSearch Features
Figure 3. Others Features
Figure 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application: 2020 VS 2026
Figure 5. Breast Cancer Diagnosis and Treatment Case Studies
Figure 6. Prostate Cancer Diagnosis and Treatment Case Studies
Figure 7. Colorectal Cancer Diagnosis and Treatment Case Studies
Figure 8. Lung Cancer Diagnosis and Treatment Case Studies
Figure 9. Other Cancers Diagnosis and Treatment Case Studies
Figure 10. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report Years Considered
Figure 11. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Regions: 2020 VS 2026
Figure 13. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Players in 2019
Figure 16. Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2019
Figure 18. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Janssen Total Revenue (US$ Million): 2019 Compared w